3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
3
Polycystic Ovary Syndrome
1
Metastatic Neuroendocrine Prostate Cancer
1
Metastatic Castration-Resistant Prostate Cancer
1
Kallmann Syndrome
1
Hypogonadism
1
Hyperprolactinemia
1
Breast Neoplasms
1
Interventions
relugolix
1
apalutamide
1
abiraterone
1
Prednisone
1
Methylprednisolone
1
Lutetium-177
1
Lutetium
1
Gonadotropin-Releasing Hormone
1
Docetaxel
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Metastatic Castration-Resistant Prostate Cancer
×
Gonadotropin-Releasing Hormone
×
Clear all
NCT06531499
2025-12-31
RADIODOSE
Novartis
Phase 1
Recruiting
106 enrolled